Advanced Oxygen Therapy

Oceanside, United States Founded: 2004 • Age: 22 yrs
Solutions for treating severe acute and chronic wounds are developed.
Annual revenue $57.2M Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About Advanced Oxygen Therapy

Advanced Oxygen Therapy is a company based in Oceanside (United States) founded in 2004. Advanced Oxygen Therapy offers products and services including TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System. Advanced Oxygen Therapy operates in a competitive market with competitors including Natrox, EO2Concepts, Vaporox, InotecAMD and Teknomar, among others.

  • Headquarter Oceanside, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aoti, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $57.22 M (USD)
    29.27
    as on Dec 31, 2024
  • Net Profit
    -$1.72 M (USD)
    79.13
    as on Dec 31, 2024
  • EBITDA
    $2.93 M (USD)
    170.69
    as on Dec 31, 2024
  • Latest Funding Round
    $12 M (USD), Debt – Conventional

    Mar 21, 2022

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Advanced Oxygen Therapy

Advanced Oxygen Therapy is a publicly listed company on the LSE with ticker symbol AOTI in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: LSE · Ticker: AOTI · Sector: Health technology · UK

Products & Services of Advanced Oxygen Therapy

Advanced Oxygen Therapy offers a comprehensive portfolio of products and services, including TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System.

Product name locked
Category locked
Primary

Delivers topical oxygen to extremities for wound healing.

Product name locked
Category locked
Locked

Provides oxygen and compression for various wound types.

Product name locked
Category locked
Locked

Supports wound management with advanced innovations.

People of Advanced Oxygen Therapy

Headcount 10-50
Employee Profiles 24
Board Members and Advisors 1
Employee Profiles
People
Marty Sylvain
Chief Advocacy Officer
People
Matthew Garoufalis
Chief Medical Officer
People
Gerry Coughlan
VP of R&D, Operations & Manufacturing
People
Stacy Reel
Chief Commercial Officer (cco)

Unlock access to complete

Board Members and Advisors
people
Doug Le Fort
Senior Strategic Advisor

Unlock access to complete

Funding Insights of Advanced Oxygen Therapy

Investors in Advanced Oxygen Therapy

Advanced Oxygen Therapy has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SWK Holdings.

All
Institutional
Investor Description Founded Year Domain Location
Investments and advisory services are provided by the holding company.
Locked Locked Locked
Premium access

Investor details for Advanced Oxygen Therapy

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Advanced Oxygen Therapy

Investments
Premium access

Investment portfolio details for Advanced Oxygen Therapy

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Advanced Oxygen Therapy

Premium access

Detailed financials for Advanced Oxygen Therapy

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Advanced Oxygen Therapy Comparisons

Advanced Oxygen Therapy Primary company
Description
Solutions for treating severe acute and chronic wounds are d...
Location
Oceanside, United States
Founded Year
2004
Annual Revenue
$57.22 M (USD)
Net Profit
-$1.72 M (USD)
EBITDA
$2.93 M (USD)
Employees
Not available
Premium access

Peer comparison for Advanced Oxygen Therapy

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Advanced Oxygen Therapy

Advanced Oxygen Therapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natrox, EO2Concepts, Vaporox, InotecAMD and Teknomar, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Oxygen-based wound therapy devices are developed for healing non-healing wounds.
Locked Locked Locked
Continuous oxygen diffusion devices for chronic wound care are developed.
Locked Locked Locked
Developer of medical device for the wound treatment
Locked Locked Locked
Chronic wound solutions are developed via portable oxygen-enrichment devices.
Locked Locked Locked
Produces sterilization devices, air sterilizers, and wound care equipment for medical use.
Premium access

Detailed competitors of Advanced Oxygen Therapy

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Advanced Oxygen Therapy

Premium access

Complete news archive for Advanced Oxygen Therapy

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Advanced Oxygen Therapy

Advanced Oxygen Therapy was founded in 2004 and raised its 1st funding round 18 years after it was founded.

Advanced Oxygen Therapy is headquartered in Oceanside, United States. It is registered at Oceanside, California, United States.

Annual revenue of Advanced Oxygen Therapy is $57.22M as on Dec 31, 2024.

Advanced Oxygen Therapy was founded in 2004 and is located in Oceanside, United States. Solutions for treating severe acute and chronic wounds are developed within the medical device sector. Operations focus on products such as single-use Topical Wound Oxygen extremity chambers, single-use Topical Wound Oxygen Sacral systems for torso wounds including pressure ulcers, and reusable extremity chambers. The companys domain is aotinc.net.

Advanced Oxygen Therapy's top competitors include Natrox, Vaporox and EO2Concepts.

Advanced Oxygen Therapy offers TWO2 Extremity Chamber, TWO2 Multi-Patch, and NEXA NPWT System.

Yes, Advanced Oxygen Therapy is publicly traded on LSE under the ticker symbol AOTI.

Advanced Oxygen Therapy has 1 investor. Key investors include SWK Holdings.

The ticker symbol of Advanced Oxygen Therapy is AOTI on LSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available